Glucose metabolism: Key endogenous regulator of β-cell replication and survival

Diabetes, Obesity and Metabolism

Volumn 14, Issue SUPPL.3, 2012, Pages 101-108

  Dadon, D ^a   Tornovsky Babaey, S ^b   Furth Lavi, J ^b   Ben Zvi, D ^c   Ziv, O ^a   Schyr Ben Haroush, R ^a   Stolovich Rain, M ^a   Hija, A ^a   Porat, S ^a   Granot, Z ^a   Weinberg Corem, N ^a   Dor, Y ^a   Glaser, B ^b  

^a HEBREW UNIVERSITY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Activating mutations; Diabetes; Glucokinase; Glucokinase activators; Glucose metabolism; Glucotoxicity; cell regeneration; cell replication

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM); DIAZOXIDE; GLUCOKINASE; GLUCOSE; INSULIN;

CELL DEATH; CELL DIVISION; CELL MATURATION; CELL PROLIFERATION; CELL REGENERATION; CELL STIMULATION; CELL SURVIVAL; CONGENITAL HYPERINSULINISM OF INFANCY; CYTOTOXICITY; EXPERIMENTAL MODEL; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEREDITY; HUMAN; HUMAN GENETICS; HYPERINSULINISM; INFANT DISEASE; INSULIN RELEASE; MITOGENESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS RESECTION; PATHOGENESIS; RECESSIVE INHERITANCE; REGULATORY MECHANISM; REVIEW;

EID: 84865601606     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2012.01646.x     Document Type: Review

References (56)

1. Rieck S, Kaestner KH. Expansion of beta-cell mass in response to pregnancy. Trends Endocrinol Metab 2010; 21: 151-158.
2. Sachdeva MM, Stoffers DA. Minireview. Meeting the demand for insulin: molecular mechanisms of adaptive postnatal beta-cell mass expansion. Mol Endocrinol 2009; 23: 747-758.
3. Bouwens L, Rooman I. Regulation of pancreatic beta-cell mass. Physiol Rev 2005; 85: 1255-1270.
4. Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004; 429: 41-46.
5. Nir T, Melton DA, Dor Y. Recovery from diabetes in mice by beta cell regeneration. J Clin Invest 2007; 117: 2553-2561.
6. Teta M, Rankin MM, Long SY, Stein GM, Kushner JA. Growth and regeneration of adult beta cells does not involve specialized progenitors. Dev Cell 2007; 12: 817-826.
7. Brennand K, Huangfu D, Melton D. All beta cells contribute equally to islet growth and maintenance. PLoS Biol 2007; 5: e163.
8. Meier JJ, Butler AE, Saisho Y et al. Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans. Diabetes 2008; 57: 1584-1594.
9. Xu X, D'Hoker J, Stange G et al. Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell 2008; 132: 197-207.
10. Thorel F, Nepote V, Avril I et al. Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss. Nature 2010; 464: 1149-1154.
11. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.
12. Herder C, Roden M. Genetics of type 2 diabetes: pathophysiologic and clinical relevance. Eur J Clin Invest 2011; 41: 679-692.
13. Weir GC, Marselli L, Marchetti P, Katsuta H, Jung MH, Bonner-Weir S. Towards better understanding of the contributions of overwork and glucotoxicity to the beta-cell inadequacy of type 2 diabetes. Diabetes Obes Metab 2009; 11(Suppl. 4): 82-90.
14. Reynoso JF, Gruessner CE, Sutherland DER, Gruessner RWG. Short- and long-term outcome for living pancreas donors. J Hepatobiliary Pancreat Sci 2010; 17: 92-96.
15. Gruessner RW, Sutherland DE, Drangstveit MB, Bland BJ, Gruessner AC. Pancreas transplants from living donors: short- and long-term outcome. Transplant Proc 2001; 33: 819-820.
16. Gruessner RWG, Pugliese A, Reijonen HK et al. Development of diabetes mellitus in living pancreas donors and recipients. Exp Rev Clin Immunol 2011; 7: 543-551.
17. Robertson RP, Lanz KJ, Sutherland DER, Seaquist ER. Relationship between diabetes and obesity 9 to 18 years after hemipancreatectomy and transplantation in donors and recipients. Transplantation 2002; 73: 736-741.
18. Glaser B. Hyperinsulinism of the newborn. Semin Perinatol 2000; 24: 150-163.
19. Kassem S, Bhandari S, Rodriguez-Bada P et al. Large islets, beta-cell proliferation, and a glucokinase mutation. N Engl J Med 2010; 362: 1348-1350.
20. Kassem SA, Ariel I, Thornton PS, Scheimberg I, Glaser B. Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes 2000; 49: 1325-1333.
21. Glaser B, Kesavan P, Heyman M et al. Familial hyperinsulinism caused by an activating glucokinase mutation. N Engl J Med 1998; 338: 226-230.
22. Cuesta-Munoz AL, Huopio H, Otonkoski T et al. Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation. Diabetes 2004; 53: 2164-2168.
23. Heitz PU, Kloppel G, Hacki WH, Polak JM, Pearse AG. Nesidioblastosis: the pathologic basis of persistent hyperinsulinemic hypoglycemia in infants. Morphologic and quantitative analysis of seven cases based on specific immunostaining and electron microscopy. Diabetes 1977; 26: 632-642.
24. Rahier J, Falt K, Muntefering H, Becker K, Gepts W, Falkmer S. The basic structural lesion of persistent neonatal hypoglycaemia with hyperinsulinism: deficiency of pancreatic δ cells or hyperactivity of β cells? Diabetologia 1984; 26: 282-289.
25. Leibowitz G, Glaser B, Higazi AA, Salameh M, Cerasi E, Landau H. Hyperinsulinemic hypoglycemia of infancy (nesidioblastosis) in clinical remission: incidence of diabetes mellitus and persistent β-cell dysfunction at long-term follow-up. J Clin Endocrinol Metabol 1995; 80: 386-392.
26. Beltrand J, Caquard M, Arnoux J-B et al. Glucose metabolism in 105 children and adolescents after pancreatectomy for congenital hyperinsulinism. Diabetes Care 2012; 35: 198-203.
27. Glaser B, Landau H, Permutt MA. Neonatal hyperinsulinism. Trends in Endocrinol and Metabol 1999; 10: 55-61.
28. deLonlay P, Fournet JC, Rahier J et al. Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. J Clin Invest 1997; 100: 802-807.
29. Ryan FD, Devaney D, Joyce C et al. Hyperinsulinism: the molecular aetiology of focal disease. Arch Dis Child 1998; 79: 445-447.
30. Fournet JC, Mayaud C, de Lonlay P et al. Unbalanced expression of 11p15 imprinted genes in focal forms of congenital hyperinsulinism: association with a reduction to homozygosity of a mutation in abcc8 or kcnj11. Am J Pathol 2001; 158: 2177-2184.
31. Fournet JC, Verkarre V, De Lonlay P et al. Loss of imprinted genes and paternal sur1 mutations lead to hyperinsulinism in focal adenomatous hyperplasia. Ann Endocrinol 1998; 59: 485-491.
32. Mazor-Aronovitch K, Gillis D, Lobel D et al. Long-term neurodevelopmental outcome in conservatively treated congenital hyperinsulinism. Eur J Endocrinol 2007; 157: 491-497.
33. Mazor-Aronovitch K, Landau H, Gillis D. Surgical versus non-surgical treatment of congenital hyperinsulinism. Pediatr Endocrinol Rev 2009; 6: 424-430.
34. Levitt HE, Cyphert TJ, Pascoe JL et al. Glucose stimulates human beta cell replication in vivo in islets transplanted into nod-severe combined immunodeficiency (scid) mice. Diabetologia 2011; 54: 572-582.
35. Bernard C, Thibault C, Berthault MF et al. Pancreatic beta-cell regeneration after 48-h glucose infusion in mildly diabetic rats is not correlated with functional improvement. Diabetes 1998; 47: 1058-1065.
36. Bonner-Weir S, Trent DF, Honey RN, Weir GC. Responses of neonatal rat islets to streptozotocin: limited β-cell regeneration and hyperglycemia. Diabetes 1981; 30: 64-69.
37. Porat S, Weinberg-Corem N, Tornovsky-Babaey S et al. Control of pancreatic beta cell regeneration by glucose metabolism. Cell Metabol 2011; 13: 440-449.
38. Pfefferkorn JA, Guzman-Perez A, Litchfield J et al. Discovery of (s)-6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid as a hepatoselective glucokinase activator clinical candidate for treating type 2 diabetes mellitus. J Med Chem 2012; 55: 1318-1333.
39. Gumbiner B, Van Cauter E, Beltz WF et al. Abnormalities of insulin pulsatility and glucose oscillations during meals in obese noninsulin-dependent diabetic patients: effects of weight reduction. J Clin Endocrinol Metab 1996; 81: 2061-2068.
40. Palumbo P, De Gaetano A. An islet population model of the endocrine pancreas. J Math Biol 2010; 61: 171-205.
41. Gilon P, Ravier MA, Jonas JC, Henquin JC. Control mechanisms of the oscillations of insulin secretion in vitro and in vivo. Diabetes 2002; 51(Suppl. 1): S144-151.
42. Tengholm A, Gylfe E. Oscillatory control of insulin secretion. Mol Cell Endocrinol 2009; 297: 58-72.
43. Simon C, Brandenberger G. Ultradian oscillations of insulin secretion in humans. Diabetes 2002; 51(Suppl. 1): S258-261.
44. Henquin JC. Regulation of insulin secretion: a matter of phase control and amplitude modulation. Diabetologia 2009; 52: 739-751.
45. Levy JC. Insulin signalling through ultradian oscillations. Growth Horm IGF Res 2001; 11(Suppl. A): S17-S23.
46. Porter SL, Wadhams GH, Armitage JP. Signal processing in complex chemotaxis pathways. Nat Rev Microbiol 2011; 9: 153-165.
47. Barkai N, Leibler S. Robustness in simple biochemical networks. Nature 1997; 387: 913-917.
48. Yi TM, Huang Y, Simon MI, Doyle J. Robust perfect adaptation in bacterial chemotaxis through integral feedback control. Proc Natl Acad Sci USA 2000; 97: 4649-4653.
49. Bennett S. Development of the pid controller. IEEE Control Syst 1993; 13: 58-65.
50. Brunner Y, Schvartz D, Priego-Capote F, Coute Y, Sanchez JC. Glucotoxicity and pancreatic proteomics. J Proteomics 2009; 71: 576-591.
51. Karunakaran U, Kim HJ, Kim JY, Lee IK. Guards and culprits in the endoplasmic reticulum: glucolipotoxicity and beta-cell failure in type ii diabetes. Exp Diabetes Res 2012; 2012: 639762.
52. Poitout V, Robertson RP. Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr Rev 2008; 29: 351-366.
53. Weir GC, Marselli L, Marchetti P, Katsuta H, Jung MH, Bonner-Weir S. Towards better understanding of the contributions of overwork and glucotoxicity to the beta-cell inadequacy of type 2 diabetes. Diabetes Obes Metab 2009; 11(Suppl. 4): 82-90.
54. Olsson R, Carlsson P-O. A low-oxygenated subpopulation of pancreatic islets constitutes a functional reserve of endocrine cells. Diabetes 2011; 60: 2068-2075.
55. Wojtusciszyn A, Armanet M, Morel P, Berney T, Bosco D. Insulin secretion from human beta cells is heterogeneous and dependent on cell-to-cell contacts. Diabetologia 2008; 51: 1843-1852.
56. Girard CA, Wunderlich FT, Shimomura K et al. Expression of an activating mutation in the gene encoding the katp channel subunit kir6.2 in mouse pancreatic beta cells recapitulates neonatal diabetes. J Clin Invest 2009; 119: 80-90.